CompletedPhase 1NCT00271570

Infliximab (Remicade) for Patients With Acute Kawasaki Disease

Studying Kawasaki disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Diego
Principal Investigator
Jane C Burns, M.D.
UCSD/CHHC
Intervention
Infliximab (Remicade)(drug)
Enrollment
24 enrolled
Eligibility
18 years · All sexes
Timeline
20042006

Study locations (1)

Collaborators

Centocor, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00271570 on ClinicalTrials.gov

Other trials for Kawasaki disease

Additional recruiting or active studies for the same condition.

See all trials for Kawasaki disease

← Back to all trials